Literature DB >> 16867203

MCI is a clinically useful concept.

Ronald C Petersen1, David S Knopman.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16867203     DOI： 10.1017/S1041610206003929

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN： 1041-6102            Impact factor:   3.878


× No keyword cloud information.
  13 in total

1.  Do general practitioners recognize mild cognitive impairment in their patients?

Authors:  H Kaduszkiewicz; T Zimmermann; H Van den Bussche; C Bachmann; B Wiese; H Bickel; E Mösch; H-P Romberg; F Jessen; G Cvetanovska-Pllashniku; W Maier; S G Riedel-Heller; M Luppa; H Sandholzer; S Weyerer; M Mayer; A Hofmann; A Fuchs; H-H Abholz; M Pentzek
Journal:  J Nutr Health Aging       Date:  2010-10       Impact factor: 4.075

2.  Clinicopathological Staging of Dynamics of Neurodegeneration and Neuronal Loss in Alzheimer Disease.

Authors:  Jerzy Wegiel; Michael Flory; Izabela Kuchna; Krzysztof Nowicki; Shuang Yong Ma; Jarek Wegiel; Eulalia Badmaev; Mony de Leon; Thomas Wisniewski; Barry Reisberg
Journal:  J Neuropathol Exp Neurol       Date:  2021-01-01       Impact factor: 3.685

3.  Mild cognitive impairment is associated with selected functional markers: integrating concurrent, longitudinal, and stability effects.

Authors:  Sanda Dolcos; Stuart W S MacDonald; Anna Braslavsky; Richard Camicioli; Roger A Dixon
Journal:  Neuropsychology       Date:  2012-01-16       Impact factor: 3.295

4.  Identifying mild cognitive impairment at baseline in the Ginkgo Evaluation of Memory (GEM) study.

Authors:  Beth E Snitz; Judith Saxton; Oscar L Lopez; Diane G Ives; Leslie O Dunn; Stephen R Rapp; Michelle C Carlson; Annette L Fitzpatrick; Steven T Dekosky
Journal:  Aging Ment Health       Date:  2009-03       Impact factor: 3.658

Review 5.  Diagnosis and biomarkers of predementia in Alzheimer's disease.

Authors:  Orestes V Forlenza; Breno S Diniz; Wagner F Gattaz
Journal:  BMC Med       Date:  2010-12-22       Impact factor: 8.775

6.  Dysfunction of the mTOR pathway is a risk factor for Alzheimer's disease.

Authors:  Sharon C Yates; Amen Zafar; Paul Hubbard; Sheila Nagy; Sarah Durant; Roy Bicknell; Gordon Wilcock; Sharon Christie; Margaret M Esiri; A David Smith; Zsuzsanna Nagy
Journal:  Acta Neuropathol Commun       Date:  2013-05-08       Impact factor: 7.801

7.  Cognitive Profiles and Atrophy Ratings on MRI in Senior Patients With Mild Cognitive Impairment.

Authors:  Marianne M Flak; Haakon R Hol; Susanne S Hernes; Linda Chang; Thomas Ernst; Andreas Engvig; Knut Jørgen Bjuland; Bengt-Ove Madsen; Elisabeth M S Lindland; Anne-Brita Knapskog; Ingun D Ulstein; Trine E E Lona; Jon Skranes; Gro C C Løhaugen
Journal:  Front Aging Neurosci       Date:  2018-11-21       Impact factor: 5.750

8.  Event-related potential and EEG oscillatory predictors of verbal memory in mild cognitive impairment.

Authors:  Jiangyi Xia; Ali Mazaheri; Katrien Segaert; David P Salmon; Danielle Harvey; Kim Shapiro; Marta Kutas; John M Olichney
Journal:  Brain Commun       Date:  2020-12-10

9.  P300 and neuropsychological assessment in mild cognitive impairment and Alzheimer dementia.

Authors:  Mario A Parra; Lindsay Lorena Ascencio; Hugo Fenando Urquina; Facundo Manes; Agustín M Ibáñez
Journal:  Front Neurol       Date:  2012-12-05       Impact factor: 4.003

10.  APOE and COMT polymorphisms are complementary biomarkers of status, stability, and transitions in normal aging and early mild cognitive impairment.

Authors:  Roger A Dixon; Correne A DeCarlo; Stuart W S MacDonald; David Vergote; Jack Jhamandas; David Westaway
Journal:  Front Aging Neurosci       Date:  2014-09-05       Impact factor: 5.750
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.